We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
301
Marriott International
MAR
$98.3B
$3.62M 0.07%
19,682
+12,321
+167% +$2.14M
CSGP icon
302
CoStar Group
CSGP
$11.7B
$3.61M 0.07%
40,561
+718
+2% +$55.4K
CRWD icon
303
CrowdStrike
CRWD
$194B
$3.55M 0.07%
96,744
+33,032
+52% +$1.15M
MTN icon
304
Vail Resorts
MTN
$5.32B
$3.54M 0.07%
14,061
+331
+2% +$80.7K
MLP icon
305
Maui Land & Pineapple Co
MLP
$344M
$3.54M 0.07%
248,279
-11,429
-4% -$144K
FDX icon
306
FedEx
FDX
$72.7B
$3.54M 0.07%
14,260
-2,130
-13% -$487K
IWO icon
307
iShares Russell 2000 Growth ETF
IWO
$14.3B
$3.53M 0.07%
14,549
+4,832
+50% +$1.11M
LUV icon
308
Southwest Airlines
LUV
$22B
$3.53M 0.07%
97,462
-625
-0.6% -$19.6K
CL icon
309
Colgate-Palmolive
CL
$73.1B
$3.5M 0.07%
45,463
+239
+0.5% +$18.5K
ATO icon
310
Atmos Energy
ATO
$28.8B
$3.43M 0.07%
29,476
+1,339
+5% +$155K
ITA icon
311
iShares US Aerospace & Defense ETF
ITA
$14.2B
$3.43M 0.07%
29,370
+2,462
+9% +$280K
FDL icon
312
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.74B
$3.41M 0.07%
100,248
-868
-0.9% -$30.1K
ULTA icon
313
Ulta Beauty
ULTA
$22B
$3.38M 0.07%
7,193
+139
+2% +$68.1K
CBRE icon
314
CBRE Group
CBRE
$42.5B
$3.38M 0.07%
41,833
+135
+0.3% +$10.1K
IEFA icon
315
iShares Core MSCI EAFE ETF
IEFA
$190B
$3.38M 0.07%
50,004
+381
+0.8% +$25.8K
OVV icon
316
Ovintiv
OVV
$17.3B
$3.37M 0.07%
+88,415
New +$3.2M
PATH icon
317
UiPath
PATH
$6.61B
$3.35M 0.07%
202,469
+25,147
+14% +$403K
JPST icon
318
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
$3.35M 0.07%
66,794
-5,481
-8% -$275K
GWW icon
319
W.W. Grainger
GWW
$65.3B
$3.33M 0.07%
4,218
+1
+0% +$689
NSC icon
320
Norfolk Southern
NSC
$75.4B
$3.32M 0.07%
14,652
-1,268
-8% -$269K
GDX icon
321
VanEck Gold Miners ETF
GDX
$22.7B
$3.3M 0.07%
109,537
+17,444
+19% +$568K
SUB icon
322
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$3.3M 0.07%
31,671
-3,388
-10% -$353K
CNI icon
323
Canadian National Railway
CNI
$76.9B
$3.29M 0.07%
27,182
+775
+3% +$91.9K
ZBH icon
324
Zimmer Biomet
ZBH
$18.2B
$3.29M 0.07%
22,588
+2,567
+13% +$349K
JEPI icon
325
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
$3.29M 0.07%
59,419
+9,318
+19% +$509K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.